Skip to content

Clinical trials

Terminated Phase 2/3 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: Germany Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20053
20069
20075
20083
20094
20115
20124
20133
20145
20158
20163
20171
20183
20196
20206
20217
20225
20235
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated93

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany4
European Organisation for Research and Treatment of Cancer - EORTC4
Novartis Pharmaceuticals4
Boehringer Ingelheim3
Alexion Pharmaceuticals, Inc.2
AstraZeneca2
Auron Healthcare GmbH2
Facet Biotech2
Gilead Sciences2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-196
Carcinoma, Non-Small-Cell Lung5
Colitis, Ulcerative5
Alzheimer Disease4
Inflammatory Bowel Diseases4
Crohn Disease3
Graft vs Host Disease3
Heart Failure3
Lung Neoplasms3
Neoplasms3

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.